-
SkIN Canada NewsSkIN Canada News
-
-
-
-
-
Featured profiles
-
-
-
From the SkIN Canada Training Committee Hub
-
-
-
From the SkIN Canada Patient Engagement hub
-
-
News from Other Organizations
-
-
-
-
-
Recent Publications by SkIN Canada Members
-
-
-
-

 Melanie Kermany is a Policy & Planning Analyst at the Natural Sciences and Engineering Research Council of Canada (NSERC) and is passionate about advocating for patients living with skin conditions. She is currently the Patient Research Partner (PRP) for the Training Committee of SkIN Canada, and has also served as a Grant Reviewer for the Canadian Skin Patient Alliance (CSPA). Natalie has a Master of Science Degree focused in Animal Behaviour from the University of Ottawa, and her interests include dermatology, intersectional environmentalism, equitable healthcare, and anti-racism work.
Â
Winter 2023
Featured profile: Early Career Investigator – Dr. Melanie LaurinÂ

Dr. Mélanie Laurin is a regular researcher in the Oncology axis of the CHU of Quebec – Laval University Research Center. She is also an associate professor in the Department of Molecular Biology, Medical Biochemistry and Pathology at Laval University. Her research activities focus on understanding the molecular mechanisms that orchestrate skin embryonic development and how these can contribute when deregulated to skin cancer progression. Throughout her career, Dr. Laurin’s work has been published in prestigious journals. Notably, one of her breakthroughs received a best publication award from the CIHR Institute of Cancer Research and was identified as a Top 10 discoveries funded by the Canadian Cancer Society in 2013. She is currently a Co-chair for the Skin Cancer Working Group of SkIN Canada and an active member of the Training Committee for SkIN Canada.
1. Who has influenced your choice of research field the most? And how? I fell in love with the skin while doing my postdoctoral training at the Rockefeller University in the lab of Dr. Elaine Fuchs, a pioneer of skin stem cell biology. During that time, I realized how powerful the skin was as a model system to address fundamental biology questions. My overarching goal as a scientist is to understand what are the molecular mechanisms that orchestrate tissue development and what happens in adult tissue when these mechanisms are perturbed. The mouse skin is an ideal model to tackle these questions since it is highly available, trackable and we have the unique ability to quickly modify gene function in this tissue, which allows us to test the consequences of these genetic perturbations on the barrier formation.
2. What are the greatest challenges you have faced or are facing in your research area? Unfortunately, like the majority of researchers, funding is a main concern. I am thoroughly grateful for all the opportunities that my team has obtained since the beginning of my career, but the level of funding remains an issue in Canada. This is why I believe that part of our duty as researchers is to share our research with the public into a more impactful message. By doing so, people will become more educated on its importance, and this will eventually translate into a clear message and request to our government to improve funding.
3. What can be done to grow the impact of skin research in Canada? I believe that the Skin Investigation Network of Canada (SkIN Canada) is doing an outstanding job at bringing fundamental and clinician scientists together. I was lucky to be introduced to the network early in my career and my interactions with its members have helped shape my research. I developed several fruitful collaborations. By promoting the network to early career investigators and trainees, and by including them in the skin research community, we will create a collaborative environment that will allow skin research to thrive.
4. If you have worked with patients as part of the research team, what did you learn? If you have not yet, what are you looking forward to learning from patient research partners? I had the opportunity of working with patients’ partner, but also to meet several via my participation to the SkIN Canada training workshops. These exchanges have always been fruitful and enriching. For example, when thinking about the identification of new therapeutics target for the treatment of skin disease, my interaction with patients has really shaped my thinking. I can now appreciate that in addition to finding new targets; we need to ensure that we identify solutions that will be compatible and that will favor patient’s adherence to treatment. Moreover, discussing with patients and partners really force scientists to move away from the usage of scientific jargon and this can only improve our ability to communicate with the public, which is essential as I mentioned earlier.
5. What are the key factors that attract trainees and early career investigators to choose skin research as their field of study? From a developmental biologist point of view, there is so many fundamental biology questions that can be ask when you study the skin. Stem cell biologists will be fascinated by the ability of skin stem cells to balance differentiation and self-renewal throughout our life to renew our barrier and repair wounds. The hair follicle is also the perfect mini organ to study their interaction with their microenvironment. The use of skin stem cells to treat burn patients is also a testament to the power of research in regenerative medicine. I could continue on and on… there is just so many questions and research avenues that can be taken!!!
Recap of SkIN Canada Workshops at 10th Annual Skin Research Group of Canada (SRGC) MeetingÂ
Workshop 1 (November 9)
Topic:Â Patient Research Engagement (Rare Skin Conditions/Skin of Color)

Moderator: Rachael Manion. Topic: Patient Research Engagement – Rare Skin Conditions/Skin of Color.
Workshop 2 (November 10)
Topic: Equity, Diversity and Inclusion (EDI)Â

Speaker 1: Dr. Diego Herrero Title: Equity, Diversity and Inclusion. Approaches to Enhance Innovation and Social Relevance of Research Projects.

Speaker 2: Dr. Nitika Pai. Title: Oh Melanin- did you just skin me? Colorism and its impact on EDI in the workplace.
Dr. Nitika Pai, a professor at McGill University and scientist at the RI-MUHC, gave her perspective on the impact of colorism on EDI in the workplace (PDF of presentation to be added to SkIN Canada website).
Skin Canada Travel and Mobility Awards – Next Application Deadline is May 15, 2024
1. The deadline for the next SkIN Canada Trainee Travel Award is Wednesday May 15 (2024) before 11:59 PM ET. SkIN Canada provides partial funding for trainees to attend conferences as part of their training experience. A limited number of awards are available each year on a competitive basis. Applicants who have previously received funding through this program in the fiscal year are not eligible to receive funding until the following fiscal year. The value of the SkIN Canada Travel Award is a maximum of $1,000 CAD.Â
Â
2. The deadline for the next SkIN Canada Trainee Mobility Award is Wednesday May 15 (2024) before 11:59 PM ET. The SkIN Canada Trainee Mobility Award provides funding for trainees in the field of skin research to study and conduct research for a brief period in a laboratory other than their own within Canada or abroad as part of their training experience. A limited number of awards are available each year on a competitive basis.  There will be two competition periods per year, one in May and one in October. Applicants are eligible for the award only once during a particular training period or level of study (e.g. MSc, Ph.D., Clinical residency, or Postdoctoral training).
    The value of the Skin Canada Trainee Mobility Award is up to $4,000 which can be used for the trainee’s research in a host laboratory within Canada or abroad for a period ranging from 2 weeks to 6 months.Â
GRIPP (Guidance for Reporting Involvement of Patients and the Public)
Although there has been more research on how to involve patients and the public in research, how patients and the public are involved and how that’s measured and evaluated is still inconsistent. This prompted a study to develop an international consensus on the key items to report to enhance the quality, transparency, and consistency of the Patient and Public Involvement (PPI) evidence base and to collaboratively involve patients as research partners at all stages in the development of GRIPP (Guidance for Reporting Involvement of Patients and the Public).
This guideline was published simultaneously in 2 journals. You can read the guideline in either of these journals using the links below.
BMJ. 2017;358:j3453. PMID: 28768629
Res Involv Engagem. 2017;3:13. PMID: 29062538
Â
CIHR-IMHA Inclusive Research Excellence Prizes Funding Opportunity


NCOHRÂ Call for Abstracts

The Association of Canadian Faculties of Dentistry (ACFD) / Canadian Association for Dental Research (CADR) and the Network for Canadian Oral Health Research (NCOHR) invites submission of research abstracts from students and junior faculty members (no more than 10 years beyond the receipt of the PhD or other equivalent degrees) at Canadian Universities for topics related to oral health. Submissions will be peer-reviewed by a conference committee panel, and selected authors will be invited to present a poster at the Canadian Oral Health Summit (COHS) held at Dalhousie University in Halifax, Nova Scotia on June 20th to 22nd, 2024.

More than Skin Deep: Mental Health Grant
Genodermatoses Network Meeting

- Croitoru DO, Brooks SG, Nathanielsz N, et al. Predictors of severity in paradoxical psoriasis from biologic therapies: A systematic review. J Am Acad Dermatol. Feb 2023;88(2):471-473.https://www.ncbi.nlm.nih.gov/pubmed/35718193
- O’Toole A, Gooderham M. Topical Roflumilast for Plaque Psoriasis. Skin Therapy Lett. Sep 2023;28(5):1-4.https://www.ncbi.nlm.nih.gov/pubmed/37734074
- Joly-Chevrier M, Gelinas A, Ghazal S, et al. Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review. Cancers. Sep 7 2023;15(18).https://www.ncbi.nlm.nih.gov/pubmed/37760419
- Osman M, Martins KJB, Wong KO, et al. Incidence and prevalence, and medication use among adults living with dermatomyositis: an Alberta, Canada population-based cohort study. Scientific reports. Sep 30 2023;13(1):16444.https://www.ncbi.nlm.nih.gov/pubmed/37777591
- Graff P, Woerz D, Wilzopolski J, et al. Extracellular Matrix Remodeling in Atopic Dermatitis Harnesses the Onset of an Asthmatic Phenotype and Is a Potential Contributor to the Atopic March. The Journal of investigative dermatology. Oct 12 2023.https://www.ncbi.nlm.nih.gov/pubmed/37838332
Â
Â
Wound Healing, Fibrosis and Regeneration
- Attiogbe E, Larochelle S, Chaib Y, et al. An in vitro autologous, vascularized, and immunocompetent Tissue Engineered Skin model obtained by the self-assembled approach. Acta biomaterialia. Sep 15 2023;168:361-371.https://www.ncbi.nlm.nih.gov/pubmed/37419164
- Khalaf F, Hutter MF, Jeschke MG. Traversing the blaze: Uncovering the challenges in burn care for older adults. Surgery. Oct 11 2023.https://www.ncbi.nlm.nih.gov/pubmed/37833154
- Sanchez-Espino LF, Sibbald C, Stimec J, Laxer RM, Pope E. Characteristics and onset of presentation of pediatric stiff skin syndrome: A retrospective cohort study of 11 patients in a tertiary care center. Pediatr Dermatol. Oct 20 2023.https://www.ncbi.nlm.nih.gov/pubmed/37864376
- Magne B, Demers A, Savard E, et al. Speeding up the production of clinical-grade skin substitutes using off-the-shelf decellularized self-assembled dermal matrices. Acta biomaterialia. Sep 1 2023;167:249-259.https://www.ncbi.nlm.nih.gov/pubmed/37285897
- Yang Y, Gomez N, Infarinato N, et al. The pioneer factor SOX9 competes for epigenetic factors to switch stem cell fates. Nature cell biology. Jul 24 2023.https://www.ncbi.nlm.nih.gov/pubmed/37488435
Â
Skin and Other Cancers
- Bergeron A, Nessim C, Kleiner O, et al. SkIN Canada Priority Setting Initiative ranks the Top Ten evidence uncertainties for Merkel cell carcinoma. The British journal of dermatology. Oct 21 2023.https://www.ncbi.nlm.nih.gov/pubmed/37864824
- Mohsen ST, Price EL, Chan AW, et al. Incidence, Mortality, and Survival of Merkel Cell Carcinoma: A Systematic Review of Population Based-Studies. The British journal of dermatology. Oct 24 2023.https://www.ncbi.nlm.nih.gov/pubmed/37874770
- Venables ZC, Levell NJ. Caution required in interpreting primary care vitiligo skin cancer data. The Journal of investigative dermatology. Sep 8 2023.https://www.ncbi.nlm.nih.gov/pubmed/37690707
- Muntyanu A, Nechaev V, Pastukhova E, et al. Burden and geographic distribution of oral cavity and oropharyngeal cancers in the Russian Federation. Frontiers in oncology. 2023;13:1197287.https://www.ncbi.nlm.nih.gov/pubmed/37601694
- Nguyen A, Xie P, Litvinov IV, Lefrançois P. Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-analysis (2009-2022). Am J Clin Dermatol. Feb 16 2023.https://pubmed.ncbi.nlm.nih.gov/36795228/
Other
- Etchegary H, Linklater S, Duquette D, et al. “I think there has to be a mutual respect for there to be value”: Evaluating patient engagement in a national clinical trial on de-implementation of low value care. Res Involv Engagem. Aug 26 2023;9(1):70.https://www.ncbi.nlm.nih.gov/pubmed/37633983
- Pope E, Lara-Corrales I, Rehmus W, et al. Pediatric Dermatology in Canada: A Broad Review of Population Needs, Workforce and Training With Proposed Solutions. J Cutan Med Surg. Oct 12 2023:12034754231204865.https://www.ncbi.nlm.nih.gov/pubmed/37823355
- Akuffo-Addo E, George A, Ogunyemi B. Skin of Color Representation at the Canadian Dermatology Association’s Annual Conferences. J Cutan Med Surg. Jul 26 2023:12034754231188441.https://www.ncbi.nlm.nih.gov/pubmed/37493270
- Joly-Chevrier M, Nguyen AX, Lesko-Krleza M, Lefrancois P. Performance of ChatGPT on a Practice Dermatology Board Certification Examination. J Cutan Med Surg. Jul 25 2023:12034754231188437.https://www.ncbi.nlm.nih.gov/pubmed/37489920
- Lagace F, D’Aguanno K, Prosty C, et al. The Role of Sex and Gender in Dermatology – From Pathogenesis to Clinical Implications. J Cutan Med Surg. Jul 4 2023:12034754231177582.https://www.ncbi.nlm.nih.gov/pubmed/37401812
SkIN Canada Executive Committee




